Product Code: ETC6182668 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The IVD market in Australia is a dynamic sector experiencing robust growth due to rising demand for early disease detection, personalized medicine, and point-of-care diagnostics. Key segments include immunoassays, molecular diagnostics, and hematology testing. The COVID-19 pandemic accelerated investment and adoption of IVD technologies, and continued public and private sector collaboration is supporting innovation and regulatory alignment.
The in vitro diagnostics (IVD) market in Australia is undergoing significant transformation with the integration of AI and digital health solutions. There`s an increasing shift toward point-of-care testing and rapid diagnostic kits, especially following the COVID-19 pandemic. Personalized medicine and the demand for molecular diagnostics are further propelling market growth, especially in oncology and infectious diseases.
In the In Vitro Diagnostics (IVD) market, one of the main challenges in Australia is the regulatory environment, which is becoming increasingly stringent. The Therapeutic Goods Administration (TGA) imposes strict guidelines on the approval and use of diagnostic tests, and navigating these requirements can be time-consuming and expensive. Furthermore, the cost of IVD tests can limit accessibility, particularly in public healthcare systems. The need for constant innovation in diagnostic technologies and the rapid adoption of new technologies also poses challenges in terms of investment and training healthcare professionals.
Australias IVD market is poised for expansion due to increasing demand for early disease detection and personalized medicine. Government support for diagnostic infrastructure and the integration of AI and molecular diagnostics open up investment prospects in laboratories, biotech startups, and diagnostic kit manufacturing. Home diagnostic kits and point-of-care testing devices also represent a high-growth segment for investment.
The In Vitro Diagnostics (IVD) market in Australia is regulated by the TGA, which ensures that diagnostic tests and devices meet rigorous safety and efficacy standards. Australian government policies focus on improving access to diagnostic testing through public healthcare systems, promoting the use of point-of-care testing, and expanding the use of IVDs for early disease detection. Additionally, the Australian government encourages research and development in IVD technologies to keep pace with advancements in medical diagnostics and improve patient care outcomes.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia IVD Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia IVD Market Revenues & Volume, 2021 & 2031F |
3.3 Australia IVD Market - Industry Life Cycle |
3.4 Australia IVD Market - Porter's Five Forces |
3.5 Australia IVD Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Australia IVD Market Revenues & Volume Share, By Technique, 2021 & 2031F |
3.7 Australia IVD Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia IVD Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Australia IVD Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia IVD Market Trends |
6 Australia IVD Market, By Types |
6.1 Australia IVD Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Australia IVD Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Australia IVD Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.4 Australia IVD Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.5 Australia IVD Market Revenues & Volume, By Software And Services, 2021- 2031F |
6.2 Australia IVD Market, By Technique |
6.2.1 Overview and Analysis |
6.2.2 Australia IVD Market Revenues & Volume, By Immunodiagnostics, 2021- 2031F |
6.2.3 Australia IVD Market Revenues & Volume, By Blood Testing, 2021- 2031F |
6.2.4 Australia IVD Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.5 Australia IVD Market Revenues & Volume, By Tissue Diagnostics, 2021- 2031F |
6.2.6 Australia IVD Market Revenues & Volume, By Clinical Chemistry, 2021- 2031F |
6.2.7 Australia IVD Market Revenues & Volume, By Other Ivd Techniques, 2021- 2031F |
6.3 Australia IVD Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia IVD Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.3.3 Australia IVD Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Australia IVD Market Revenues & Volume, By Cardiac Diseases, 2021- 2031F |
6.3.5 Australia IVD Market Revenues & Volume, By Immune System Disorders, 2021- 2031F |
6.3.6 Australia IVD Market Revenues & Volume, By Nephrological Diseases, 2021- 2031F |
6.3.7 Australia IVD Market Revenues & Volume, By Gastrointestinal Diseases, 2021- 2031F |
6.4 Australia IVD Market, By End Users |
6.4.1 Overview and Analysis |
6.4.2 Australia IVD Market Revenues & Volume, By Standalone Laboratories, 2021- 2031F |
6.4.3 Australia IVD Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Australia IVD Market Revenues & Volume, By Academic And Medical Schools, 2021- 2031F |
6.4.5 Australia IVD Market Revenues & Volume, By Point Of Care Testing, 2021- 2031F |
6.4.6 Australia IVD Market Revenues & Volume, By Others End-User, 2021- 2031F |
7 Australia IVD Market Import-Export Trade Statistics |
7.1 Australia IVD Market Export to Major Countries |
7.2 Australia IVD Market Imports from Major Countries |
8 Australia IVD Market Key Performance Indicators |
9 Australia IVD Market - Opportunity Assessment |
9.1 Australia IVD Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Australia IVD Market Opportunity Assessment, By Technique, 2021 & 2031F |
9.3 Australia IVD Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia IVD Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Australia IVD Market - Competitive Landscape |
10.1 Australia IVD Market Revenue Share, By Companies, 2024 |
10.2 Australia IVD Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |